Literature DB >> 6344614

Systemic bacterial infections in neonatal deaths.

L Eisenfeld, R Ermocilla, D Wirtschafter, G Cassady.   

Abstract

Bacterial were identified in 126 blood and CSF cultures obtained in 311 consecutive neonatal deaths (41%). These postmortem cultures were of diagnostic value, providing the sole means for definitive bacteriologic diagnosis in 82 (65%) of the 126 infected infants. Similarity of organisms found in specimens before and after death (identical in 25 of 26), similar identity of organisms identified by histologic Gram's stain and culture (the same in 48 of 49), and the identical nature of organisms identified from blood and CSF sites (the same in 43 of 43) support the validity of these cultures. Bacterial infection remains a serious problem in neonatal intensive care. The scope of this problem may be underestimated if postmortem cultures are not obtained.

Entities:  

Mesh:

Year:  1983        PMID: 6344614     DOI: 10.1001/archpedi.1983.02140330029008

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  5 in total

Review 1.  Postmortem bacteriology: a re-evaluation.

Authors:  J A Morris; L M Harrison; S M Partridge
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Serum IgG at birth in preterm appropriate- and small-for-gestational age newborns.

Authors:  M Sharma; D Laroia; R K Taluja; P S Mathur
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

Review 3.  Anti-idiotypic antibodies as vaccines against carbohydrate antigens.

Authors:  M A Westerink; M A Apicella
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe.

Authors:  M O Ikeogu; B Wolf; S Mathe
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

5.  Effect of nutritional and HIV status on bacteraemia in Zimbabwean children who died at home.

Authors:  B H Wolf; M O Ikeogu; E T Vos
Journal:  Eur J Pediatr       Date:  1995-04       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.